Staar Surgical (STAA) Common Equity (2010 - 2026)

Staar Surgical's Common Equity history runs 17 years deep, the most recent figure standing at $352.4 million for Q2 2026.

• Quarterly Common Equity rose 0.68% year-over-year to $352.4 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $352.4 million (up 0.68% YoY) and the FY2026 annual result came in at $344.2 million, down 13.38% from the prior year.
• Common Equity was $352.4 million for Q2 2026 at Staar Surgical, up from $344.2 million in the prior quarter.
• Across five years, Common Equity topped out at $428.1 million in Q3 2024 and bottomed at $276.3 million in Q2 2022.
• A 5-year average of $356.9 million and a median of $352.4 million in 2026 frame the typical range for Common Equity.
• Annual changes were most pronounced in 2022 — Common Equity advanced 29.72% — and 2025, when it decreased 17.73%.
• Staar Surgical's Common Equity stood at $336.1 million in 2022, then climbed by 14.83% to $386.0 million in 2023, then climbed by 2.95% to $397.3 million in 2024, then dropped by 10.96% to $353.8 million in 2025, then fell by 0.4% to $352.4 million in 2026.
• Business Quant data shows STAA's Common Equity at $352.4 million in Q2 2026, $344.2 million in Q1 2026, and $353.8 million in Q3 2025.